The indirect labeling cDNA microarray technique was used to evaluate gene expression profiles of pure cell populations from frozen sections of carcinomas and adenomas harvested from precancerous hepatocellular lesions by using laser capture microdissection (LCM). The levels of differentially expressed genes were investigated using a cDNA microarray with 9,984 features with only 2 ug of two-round amplified aRNA, equivalent to 35 cells from LCM-adenomas and frozen samples of carcinomas from simian virus 40 (SV40) large T antigen transgenic rats. A total of 855 genes were identified as being 3-fold or more differentially expressed in carcinomas or adenomas as compared to normal tissue controls. Among these 855 genes, 71 genes were differentially expressed in both carcinomas and adenomas. Commonly up-regulated genes in both carcinoma and adenomas were 28 while 41 of the 71 genes were commonly down-regulated. Two genes, Igh1 (immunoglobulin heavy chain 1(Serum IgG2a), Image clone ID: 875880) and EST clone (AI893585, Image clone ID: 596604) were more than 7-fold up-regulated in carcinomas and 6-fold down-regulated in adenomas. In Cy5 and Cy3 reciprocal experiments for screening out false positive signals, the amplified carcinomas showed higher Pearson Correlation Coefficient values (−0.94 and −0.92) than the LCM-amplified adenoma samples (−0.79 and −0.84). LCM-amplified samples provided higher signal intensities over backgrounds and a greater average of Cy5:Cy3 ratios. Expression levels of mRNAs from selected genes, determined by using traditional dot blot analysis, revealed that 36 of 40 tested expression profiles were consistent with the microarray data. Thus, amplified aRNA harvested from homogeneous cell types using LCM can be applied to study gene expression profiles by use of microarray analysis.
INTRODUCTION
Microarray techniques have been used for studying the genetic profiles of various tissues and cell lines. Recently, cell specific gene expression pattern profiles have been in great demand especially for analyzing nonhomogeneous tissues such as solid tumors (10, 16) . Traditionally, more than 20 ug of total RNA per channel is required for direct labeling cDNA microarray analysis. Often, tissue samples that yield sufficient RNA for cDNA microarray analysis contain various mixed cell types including blood vessels, connective tissues, extracellular matrix, and many others. For this reason, obtaining quality RNA from homogeneous cell types derived from biologically heterogeneous tissues has been a major challenge. To overcome this hurdle, LCM and other methods have been suggested for mRNA (2, 9) as well as proteomics studies (14) . The LCM method provides great advantages in harvesting pure cell populations in specific histopathologic lesions in tissue sections but requires preprocessing including freezing and fixing, which may degrade RNA and alter the generic character of interesting targets (12) . Because LCM provides only very limited quantities of RNA, further amplification of RNA is necessary in order to perform cDNA microarray analysis. Using T7 polymerase, RNA amplification has been suggested for microarray analysis (15) . To evaluate whether LCM-amplified RNA reflects the molecular level of specificity for the target cell types and the biological characteristics observed in vivo, comparative cDNA microarrays were performed using amplified hepatocellular precancerous lesions and carcinomas, and LCM-adenomas.
EXPERIMENTAL PROTOCOL Transgenic Rat
A transgenic rat containing the mouse albuminpromoter/enhancer linked to the coding region of the simian virus 40 large T antigen (SV 40 Tag) was generated to examine liver cancer development (8) . Cytogenetic analysis has been performed on liver and tumors that develop in this rat model (11) . Selective loss of nucleoside carrier proteins in this model has also been demonstrated (3) .
Pathology
The following rat liver samples were obtained: frozen liver from a normal nontransgenic Sprague-Dawley (SD) rat 295 TOXICOLOGIC PATHOLOGY (Nor.); two frozen hepatocellular carcinomas from SV40Tag transgenic rats (T90 and T68); and microdissected liver tissues using laser capture microdissection (LCM) of frozen tissue sections-histologically normal liver in the transgenic rat (normal-LCM), and two histological hepatocellular adenomas from the transgenic rat (adenoma A-LCM and adenoma B-LCM). Frozen sections of adenoma A and B were prepared for histological examination by formalin fixation, paraffin embedding, and staining with hematoxylin and eosin (H&E). Two carcinoma lesions were first frozen, then thawed, fixed in formalin, and embedded in paraffin for sectioning and staining with H&E.
Laser Capture Microdissection (LCM)
Frozen tissues were sectioned at 8 µm, eosin-stained, and microdissected with the use of a PixCell II laser capture microscope with an infrared diode laser (Arcturus Engineering, Santa Clara, CA) as described (1, 5) . Cells were laser captured from two separate adenomas within the same liver (Adenoma A and Adenoma B). Normal liver from the same sections was laser captured as a control.
RNA Amplification
Total RNAs from normal (Nor.), tumor 90 (T90), tumor 68 (T68), normal-LCM, adenoma A-LCM, and adenoma B-LCM were isolated using the StrataPrep total RNA microprep kit (Stratagene, La Jolla, CA). Total RNAs isolated from carcinomas and LCM samples were subjected to two rounds of T7-based RNA amplification (4) by using the RiboAmp RNA amplification kit (ARCTURUS, Mountain View, CA) according to the manufacturer's instruction.
cDNA Microarray
Each of 2 ug of amplified aRNAs from testers and their normal controls and 2 ul of N6 random hexamer (2 ug/ul) in a final volume of 25 ul were denatured at 65
• C for 5 minutes followed by cooling to room temperature. Synthesized aminoallyl-cDNA was synthesized using Superscript II (Gibco-BRL) reverse transcriptase with 1 ul of rRNasin (Promega, Madison, WI), 500 uM of dATP, dCTP, dGTP and 200 uM of dTTP (Amersham, Piscataway, NJ) and 300 uM of aminoallyl-dUTP (Sigma, St. Louis, MO) at 42
• C for 1 hour. Aminoallyl-cDNA was heated at 70
• C for 5 minutes followed by Ribonuclease H (Promega, Madison, WI) digestion at 37
• C for 20 minutes. A 0.5 ul aliquot of 0.5 M EDTA was added to aminoallyl-cDNA followed by purification using the QuickClean purification resin (Clontech, Palo Alto, CA). Ethanol precipitated aminoallyl-cDNA was dissolved in 10 ul of 50 mM of sodium bicarbonate (pH 9.0) and coupled with Cy5 or Cy3 dye (Amersham Pharmacia, Piscataway, NJ) with occasional vortexing at room temperature for 2 hours. Cy3-coupled and Cy5-coupled cDNA probes were ethanol precipitated, washed with 70% ethanol, and dissolved in 100 ul of TE buffer (pH 7.4). Cy5 and Cy3 coupled cDNA probes were combined, washed twice with TE buffer using Microcon YM-30 (Millipore, Bedford, MA), and adjusted to a final volume of 11 ul.
An NCI mouse cDNA array slide (IncyteGem2 with a total of 10,368 features including 9984 UniGene mouse clone set) was prehybridized at 42
• C for 1 hour using 0.1% SDS, 1% BSA, and 5X SSC. Prehybridized slides were washed in water for 2 minutes followed by 2 minutes in 100% isopropanol and then spin-dried at room temperature for 5 minutes at 500 g.
The probe (11 ul) was combined with 1 ul of COT-1 DNA (10 ug/ul), 1 ul yeast t-RNA (4 ug/ul), 1 ul of poly A (10 ug/ul), and 1 ul of T7 primer (1 ug/ul, AAA CGA CGG CCA GTG AAT TGT AAT ACG ACT CAC TAT AGG CGC T) and boiled for 1 minute followed by snap cooling on wet ice. A 15 ul aliquot of 2X hybridization buffer (49% formamide, 9.8X SSC, 0.2% SDS) at 42
• C was combined into 15 ul of probe mixture and loaded onto a cDNA microarray slide. The slide was hybridized at 42
• C for 12-16 hours in a water bath followed by washing for 2 minutes in 2X SSC and 0.1% SDS, 1 minute in 1X SSC, 1 minute in 0.2X SSC, 20 seconds in 0.05X SSC and spin-drying at room temperature for 5 minutes at 500 g. All experiments were performed at least twice by switching dyes reciprocally.
Image Analysis
Slides were scanned by using a GenPix 4000A (Axon, Union City, CA). Obtained GPR (gene pix result) data were analyzed using NCI microarray analysis tools http://nciarray.nci.nih.gov to achieve background subtraction and normalization between arrays. Data from reciprocal experiments were recalculated by taking reciprocal values and averaged with nonreciprocal data values. Twodimensional hierarchical clustering analysis was accomplished by using Cluster and TreeView Eisen clustering tools (13) http://rana.lbl.gov . The genes were filtered with a minimum standard of at least a 3-fold change in expression level compared to normal tissue.
Dot Blot Analysis and Confirmation
Clones were purchased from Research Genetics (Huntsville, AL). A dot blot was prepared by applying 50 ng of each probe to a positively charged nylon membrane (GeneScreen Plus, NEN Life Science Products Inc, Boston, MA). The membranes were hybridized with [
32 P]-labeled cDNA probes derived from second round amplified aRNA from carcinomas (T90 and T68), adenomas (LCM-adenoma A and LCM-adenoma B), and normal controls (normal and LCM-normal) using ULTRAhyb (Ambion, Austin, TX) according to the manufacture's protocols. Scanning densitometry and signal intensity quantification was performed using a Storm Phosphoimager (Molecular Dynamics, Amersham Bioscience, Piscataway, NJ) with ImageQuant (Amersham Pharmacia Biotech, Piscataway, NJ) software. Relative spot intensities were obtained after background subtraction and normalization with the signal for beta-actin on the same membrane. Relative spot intensities in carcinomas and LCM-adenomas were compared with normal control samples.
RESULTS AND DISCUSSION
The pathology of hepatocarcinogenesis in the simian virus 40 large T antigen (SV40Tag) transgenic rat was previously reported (8) . Hepatocellular adenomas (lower left, adenoma B), which are thought to be precancerous lesions, and normal hepatocytes (upper right, normal) in the same section were laser captured ( Figure 1A ). Hepatocellular carcinomas (T90 and T68), in areas of gland formation were observed and frozen sections were prepared for histological examination by formalin fixation ( Figure 1B ). Total RNAs prepared from LCM cells, carcinoma tissues, and normal tissue, were amplified using T7-polymerase. To optimize the amplification and microarray conditions, the starting materials were approximately 3,000 cells from LCM-adenomas and LCM-normal controls. The average yield of aRNA after a second round amplification of total RNA obtained from LCM-adenomas and LCM-normal controls, was 180 ug, which is the equivalent of 60 ng/cell. Two ug of aRNA from LCM-adenomas and LCM-normal cells (equivalent to 35 cells) were compared using the indirect labeling microarray method. Because the yield was up to 0.1 ug per cell in some cases, this method should allow for a smaller numbers of cell samples to be used for microarray analysis. The amplified aRNAs ranged between 200 bp and 800 bp. The size distributions of amplified aRNAs between carcinomas and LCM-adenomas and their normal controls were similar as judged by 1.5% agarose gel electrophoresis with EtBr staining (data not shown).
Four different comparison studies; amplified normal tissue (Cy5) versus amplified tumor 90 (Cy3), amplified normal tissue (Cy5) versus amplified tumor 68 (Cy3), LCM-amplified normal tissue (Cy5) versus LCM-amplified adenoma A (Cy3), and LCM-amplified normal tissue (Cy5) versus LCMamplified adenoma B (Cy3) and two control studies, amplified normal tissue (Cy5) versus amplified normal tissue (Cy3) and LCM-amplified normal tissue (Cy5) versus LCMamplified normal tissue (Cy3) were processed. All the experiments were reciprocally performed by swapping the Cy5 and Cy3 dyes. No further statistical analysis to check the credibility of each gene expression profile has been evaluated since reciprocal experiments and two replicates were performed for each study. By using the GenPix scanning method, more than 95% of the spots were filtered as a "good spot" in their feature size (100 to 200 um) with a two or higher ratio in its intensity of the spot over background. The good spots were used for the further analysis. The expression values in each slide were then normalized with background as well as controls and intensity of each individual array by using normalization factors using GenPix software and NCI array tools.
Microarray analysis revealed a total of 855 genes that were differentially expressed in adenomas and carcinomas compared to normal control samples. Figure 2 showed two-dimensional hierarchical clustering of two carcinomas and two LCM-adenomas compared to their normal controls. Genes filtered by the standard of "any one ratio of Cy5:Cy3 in four comparison studies being more than 3-fold different as compared with their normal controls" are shown as a cluster. Thus, the genes that were listed were those that exhibited 3-fold or more differential expression among all four comparison ratios. Carcinomas (amplified T 90 and amplified T68), LCM-adenomas (amplified LCMadenoma A and amplified LCM-adenoma B), and their normal controls (amplified normal and LCM-amplified normal) were clustered with each other. Including 3 RIKENs and 11 ESTs, 71 genes were differentially expressed more than 3-fold higher or lower in carcinomas and adenomas when compared to the corresponding normal controls (Table 1 ). Fold differences were calculated by ratios of mean intensities minus median background in Cy5 channel and mean intensities minus median background in Cy3 channel. Twenty-eight genes were commonly upregulated and 41 genes were commonly down-regulated in both carcinomas and LCM-adenomas as compared to normal controls. All three cell cycle regulated genes were up-regulated while cytochrome P450 genes were highly down-regulated in both LCM-adenomas and carcinomas. CYP1A2 (IMAGE: 680035), the most differentially expressed gene, was 0.035-and 0.015-fold down-regulated in carcinomas and adenomas, respectively as compared with normal controls. On average, mRNAs encoding breast cancer 1 (Brca1, IMAGE: 643280), microtubule-associated protein 1B (Mtap1b, IMAGE: 350186), cell division cycle 2 homolog A (Cdc2A, IMAGE: 2102122), and retinoblastoma-like 1 (Rbl1, IMAGE: 1227032) were at least 10-fold or higher in carcinomas and adenomas than in normal liver cells. Seventy one genes showing either 3-fold up-regulated or 3-fold down-regulated in both carcinomas and adenomas. Genes in bold type were compared using dot blot analysis. Ratios obtained from dot blot analysis were compared in parentheses.
the EST clone, AI893585 is located on mouse chromosome 12 and encodes the Mus musculus immunoglobulin heavy chain 1 alpha constant region (IgA). By using InterPro protein domain search http://www.ebi.ac.uk/interpro/ scan.html , this EST was found to encode four domains, immunoglobulin/major histocompatibility complex (Pfam The confidence of genetic expression profiles and the microarray method was evaluated by reciprocal experiments using cross labeling with Cy dyes. The traditional direct labeling method presents great difficulty in balancing Cy5 and Cy3 dyes because the Cy5 dye has a higher molecular weight and bulkier structure and is incorporated into DNA less efficiently. In the indirect labeling method, using a two-step labeling scheme, reverse transcription with aminoallyl-dUTP followed by direct incorporation of Cy dyes into the aminoallyl-cDNA, thus providing equally balanced two color cDNA labeling. The ratios between log 10 values of tester-Cy5: control-Cy3 versus control-Cy5: testerCy3 were plotted in Figure 3 . Pearson's correlation (Pearson Product Moment Correlation) values between reciprocal experiments from amplified carcinomas versus normal were −0.94 and −0.92 while that of the adenomas-LCM amplified versus normal LCM amplified controls were −0.84 and −0.79. In addition to the comparison of Pearson's correlation values, the distribution of the scatter plot from carcinomas showed lean and linear shapes. The LCM amplified adenomas showed more of a triangular shape in the center of the scatter plot. In this specific region, the degrees of differentially expressed ratios of LCM-amplified adenomas versus normal tissue controls and their reciprocal experiment were mini- mum (Cy5:Cy3 ratio ∼ = 1), which also indicates that genes in this region may have less reproducibility.
The ratios of red channel (Cy5) and green channel (Cy3) balance were calculated by mean intensities minus median background using an NCI software tool (mAbd Array Histogram V, beta 0.2). The histogram of Cy5:Cy3 ratio distribution revealed that samples from LCM showed higher signal intensities compared to background. Control studies using the two reciprocal labeling method showed average Cy5:Cy3 intensities of 1.007 in carcinomas and 0.999 in LCM-adenomas. Average intensity ratios of the Cy5:Cy3 ratio and reciprocal value of the Cy3:Cy5 ratio in each reciprocal study were 2.825 and 3.182 in amplified tumors (T90 and T68) and LCM-amplified adenomas, respectively. As shown in Table 1 and Figures 2, 3, and 4 , the variation of the color scheme and the actual values of the expression profiles in the carcinoma were tighter than that of the LCM-adenoma samples (expression ratios in carcinoma range from 0.03 to 14. Table 1 were 0.901 for the carcinomas while that for the LCMadenomas was 0.936. This implicates that among the highly differentially expressed genes, the LCM-adenomas showed more reproducibility in between samples and were more tightly correlated to each other than that of the carcinomas.
Overall, LCM-amplified samples exhibited an increased sensitivity for detecting changes in gene expression as compared to amplified carcinomas using the indirect labeling cDNA microarray method that may introduce false positive ratios.
Differential changes in gene expression were confirmed by traditional dot blots ( Figure 5 ). β-actin served as a loading control in dot blot analysis because the array itself contained β-actin as control spots. Eleven clones were spotted in one membrane including β-actin and hybridized with [
32 P]-labeled cDNA probes that were derived from same pools of samples as previously used for microarray experiments. Even though 11 clones were spotted in the same membrane and hybridized with six different probes, each clone independently represented mRNA expression levels of each gene in each tissue. After normalization by background, β-actin for loading control, and expression levels of normal tissues, a total of 40 individual data points were selected for evaluation by dot blot analysis. Thirty-six out of 40 identified alterations were consistent with the microarray results. Among the 36 tests, SLC27a2 and CYP2C37 showed greater differences in relative expression, while Cdc2a and CYP1A2 showed smaller differences in relative expression using dot blot analysis as compared to changes detected with microarray analysis.
Comparison of unamplified tumor mRNA with LCMamplified adenoma and carcinoma was technically difficult with several reasons. The average length of amplified aRNAs were shorter than the unamplified mRNA that results in a higher incorporation rate in amplified aRNAs compared to full-length mRNAs. It also appears that a major bias was introduced by the two different types of primers that were used for reverse transcriptation. The N6 random primer was used for amplification of aRNAs since the aRNAs do not contain polyA tails whereas oligo dT was necessary for mRNA reverse transcription to produce aminoallyl-cDNA.
In conclusion, cDNA microarray using amplified aRNA from a small number of cells revealed a number of genetic alterations in gene expression profiles between in transgenic rat hepatocellular carcinomas and adenomas as compared to normal control tissues. Some of these changes in gene expression are consistently found between adenomas and carcinomas, while others are uniquely different. The harvesting of pure cell populations using the LCM method has great potential for analyzing cell type specific global gene expression profiles.
